Growth hormone releaser attenuates β-amyloid (1-42)-induced memory impairment in mice

Journal of Pharmacological Sciences

Volumn 99, Issue 1, 2005, Pages 117-120

  Shin, Eun Joo ^a,c   Jin, Hyeong Jhoo ^b   Nabeshima, Toshitaka ^c   Jhoo, Wang Kee ^a   Myung, Sang Kwon ^a   Lim, Yong Kwang ^a   Jong, Seok Chae ^a   Myung, Eun Jung ^a   Seok, Joo Park ^a   Kyung, Jin Jang ^a   Kim, Hyoung Chun ^a  

^a Kangwon National University   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloid beta protein; Cognitive enhancer; Growth hormone releaser

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[1-42]; ARGININE; GLUTAMINE; GLYCINE; LYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GROWTH HORMONE RELEASE; HIPPOCAMPUS; MALE; MEMORY DISORDER; MOUSE; NONHUMAN;

EID: 25444447694     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.SC0050105     Document Type: Article

References (15)

1. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science. 1997;278:419-424.
2. van Dam PS, Aleman A, de Vries WR, Deijen JB, van der Veen EA, de Haan EH, et al. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm IGF Res. 2000;Suppl B:S69-S73.
3. Obermayr RP, Mayerhofer L, Knechtelsdorfer M, Tragl KH, Geyer G. The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease. Gerontology. 2003;49:191-195.
4. Khorram O. Use of growth hormone and growth hormone secretagogues in aging: help or harm. Clin Obstet Gynecol. 2001;44:893-901.
5. Chromiak JA, Antonio J. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition. 2002;18:657-661.
6. Jhoo JH, Kim HC, Nabeshima T, Yamada K, Shin EJ, Jhoo WK, et al. beta-Amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res. 2004;155:185-196.
7. Yamada K, Tanaka T, Mamiya T, Shiotani T, Kameyama T, Nabeshima T. Improvement by nefiracetam of β-amyloid-(1-42)-induced learning and memory impairments in rats. Br J Pharmacol. 1999;126:235-244.
8. National Research Council. Neutrient requirement of laboratory animals-mouse. Washington DC: National Academic Press; 1978; p. 38-53.
9. Kwon MS, Shin EJ, Nabeshima T, Kim YS, Park SJ, Jin CH, et al. Growth hormone booster attenuates memory impairment and oxidative stress in the genetic model of aging gene Klotho mutant mice. Society for Neuroscience. 2004;34:Abstract No 450.10.
10. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone re;ease and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA. 2004;101:4679-4684.
11. Israel M, Lesbats B. Application to mammalian tissue of the chemiluminiscent method for detecting acetylcholine. J Neurochem. 1982;39:248-250.
12. Moya-Quiles MR, Villalba-Sanchez J, Munoz-Delgado E, Vidal CJ. Alkaline treatment of muscle microsomes releases amphiphilic and hydrophilic forms acetylcholinesterase. Biochim Biophys Acta. 1992;1121:88-96.
13. Nitta A, Fukuta T, Hasegawa T, Nabeshima T. Continous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol. 1997;73:51-57.
14. Woelfle J, Chia DJ, Rotwein P. Mechanism of growth hormone (GH) action. J Biol Chem. 2003;278:51261-51266.
15. Brillion D, Nabil N, Jacobs LS. Cholinergic but not serotonergic mediation of exercise-induced growth hormone secretion. Endocr Res. 1986;12:137-146.